Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-13
1993-11-23
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544244, 544284, 544287, 544288, 544289, A61K 31505, C07D23990
Patent
active
052644391
ABSTRACT:
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists. ##STR1##
REFERENCES:
patent: 3360518 (1967-12-01), Shetty
patent: 4522945 (1985-06-01), Vandenberk et al.
patent: 4849518 (1989-07-01), Glazer
Dhanoa Daljit S.
Fitch Kenneth J.
Greenlee William J.
Hangauer David
Patchett Arthur A.
Camara Valerie J.
DiPrima Joseph F.
Ivy C. Warren
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Quinazolinone, triazolinone and pyrimidinone angiotensin II anta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolinone, triazolinone and pyrimidinone angiotensin II anta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone, triazolinone and pyrimidinone angiotensin II anta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849097